Beam Therapeutics Inc. (BEAM) is gearing up to release four abstracts at the upcoming American Society of Hematology [ASH] annual meeting in 2024. The thing is that the company notes in its earnings ...
Nuvectis Pharma (NVCT) had a bit of a problem back in November of 2024 because that's when its stock traded lower by as much as 45% when it released data from its phase 1b study using NXP800 for the ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic ...
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results